Antibiotic Susceptibilities in Intensive Care: Gram Positive Gram Negative
Antibiotic Susceptibilities in Intensive Care: Gram Positive Gram Negative
Antibiotic Susceptibilities in Intensive Care: Gram Positive Gram Negative
S. epidermidis Enterococcus
Clostridium1, Bacteroides, Neisseria Haemophilus Proteus ESCHAPPM2
MRSA (coagulase -ve MSSA Streptococcus Moraxella E.coli Klebsiella Pseudomonas Legionella
Peptostreptococcus Fusobacterium meningitidis in uenzae mirabilis organisms
Staphylococcus)
Faecium Faecalis
Penicillin Penicillin
Amoxicillin3 Amoxicillin
Amoxicillin-
Amoxicillin-clavulanate
clavulanate
Flucloxacillin Flucloxacillin Azithromycin,
For simplicity, atypical organisms are not included above. Partial columns indicate incomplete coverage. ESBL-producing organisms are not susceptible to most antibiotics containing a beta-lactam ring; carbapenems are the usual agent of choice.
1: C. di cile should only be treated with metronidazole or vancomycin. 2: ESCHAPPM are β-lactamase producing organisms. These are Enterobacter, Serratia, Citrobacter freundii, Hafnia, Acinetobacter/Aeromonas, Proteus (not mirabilis), Providencia & Morganella morganii.
3: Not e ective against Clostridium. 4: Metronidazole is not e ective against Peptostreptococcus, 5: Teicoplanin is not e ective against Enterococcus faecium, 6: Gentamicin is not appropriate mono therapy for Staphylococcus aureus & should only be used in conjunction with a β-lactam.
7: Due to increasing MIC, Cefuxorime is not recommended therapy for Moraxella. 8: Although it has other actions, Ceftazidime should only be used for Pseudomonas.
*This chart is intended as a guide, pending speci c identi cation & sensitivities - it does not replace expert ID advice. Local antibiotic sensitivities & preferences will vary.
fl
fl
fl
fl
ffi
fl
fl
ff
fi
ff
fi
ff